LAVQX
Price
$14.56
Change
-$0.06 (-0.41%)
Updated
May 23 closing price
Net Assets
1.89B
VIVIX
Price
$65.92
Change
-$0.08 (-0.12%)
Updated
May 23 closing price
Net Assets
183.65B
Interact to see
Advertisement

LAVQX vs VIVIX

Header iconLAVQX vs VIVIX Comparison
Open Charts LAVQX vs VIVIXBanner chart's image
Lord Abbett Fundamental Equity R2
Price$14.56
Change-$0.06 (-0.41%)
VolumeN/A
Net Assets1.89B
Vanguard Value Index I
Price$65.92
Change-$0.08 (-0.12%)
VolumeN/A
Net Assets183.65B
LAVQX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVQX vs. VIVIX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVQX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. LAVQX (1.89B). VIVIX pays higher dividends than LAVQX: VIVIX (2.35) vs LAVQX (0.56). LAVQX was incepted earlier than VIVIX: LAVQX (18 years) vs VIVIX (27 years). LAVQX (1.30) is less costly to investors than VIVIX (0.04). LAVQX is a more actively managed with annual turnover of: 39.00 vs. VIVIX (9.00). LAVQX has a lower initial minimum investment than VIVIX: LAVQX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 5.52 vs. LAVQX (2.71). VIVIX return over 5 years is better than : 74.27 vs. LAVQX (54.84).
LAVQXVIVIXLAVQX / VIVIX
Total Expense Ratio1.300.043,250%
Annual Report Gross Expense Ratio1.300.043,250%
Fund Existence18 years27 years-
Gain YTD-0.342-0.139247%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.89B184B1%
Annual Yield % from dividends0.562.3524%
Returns for 1 year2.715.5249%
Returns for 3 years22.4320.90107%
Returns for 5 years54.8474.2774%
Returns for 10 years14.0798.2114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRVI6.290.11
+1.78%
Trevi Therapeutics
ESE178.400.45
+0.25%
ESCO Technologies
SSY0.85N/A
-0.12%
SunLink Health Systems
EQH51.80-0.33
-0.63%
Equitable Holdings
SKLZ6.05-0.49
-7.49%
Skillz